Tag Archives: antibody drug conjugates

26Oct/18

The Success of Seattle Genetics/Wutian ADC Adcetris for Phase III Clinical Surgery of Peripheral T Cell Lymphoma (PTCL)

October 03, 2018 – Seattle Genetics and Takeda recently announced the evaluation of antibody conjugates Adcetris (brentuximab vedotin) for the treatment of peripheral T-cell lymphoma (PTCL, also known as mature Phase IIIRead More…

21Jul/18
What is ADC

Creative Biolabs’s Expert Advanced Professional Opinions in an Exclusive Interview with Biocompare

Recently, Yuning Chen, Ph.D., from Creative Biolabs was exclusively interviewed by  Angelo DePalma, a journalist from Biocompare,  and shared his forward-looking and professional view on antibody-drug conjugates( ADCs). Antibody-drug conjugates (ADCs) are a new implementationRead More…